The same person as above shows no signs of<unk>  during a treatment with pimecrolimus.<unk>  is one out of multiple manifestations of the reactive arthritis. Right now, topical corticosteroid therapy is the most commonly used treatment, and topical calcineurin inhibitors have also been used successfully. Newer tests on patients showed that a less harmful off-label topical treatment with the immunomodulator pimecrolimus or the immunosuppressant tacrolimus can prevent all visible symptoms of this disease. Since reactive arthritis cannot be healed as such, affected people are forced to a continuous topical treatment – otherwise they will again note first symptoms after three to four days without it. However, strong debates and controversies continue regarding the exact indications of immunomodulators like pimecrolimus and their duration of use in the absence of active controlled trials. A study released in 2015 (tested were 7,457 children with a total of 26,792 person-years) did not find any evidence that pimecrolimus could cause cancer.
Balanitis circinata
Dens evaginatus
Mania errabunda
Tinea imbricata
Chirurgia magna
Pachyonychia congenita
Lichen striatus
Corona phlebectatica